Eric Palmer

“As David noted, as you noted, we announced yesterday a couple of additional enhancements that just build on our track record of innovations to make medicines more affordable.”

“As we find at our Investor Day earlier this year, the Specialty market is a $400 billion market and growing. We're leaders in this space, driven by our focused condition-specific model, our clinical expertise and our overall geographic reach.”

“I'll start then maybe invite David to add some additional comments on the end here. But overall, our foundational pharmacy benefit services business, Express Scripts is off to a really good start for 2025.”

“But first, let me just talk a bit about the portfolio of services that we're focused on in terms of Evernorth and transition that into some of the drivers of growth specifically for 2024.”

“There is significant interest and need from our clients regarding the InCircle Rx program and assistance with GLP-1s in general. They are looking for help in managing affordability and ensuring that they achieve positive outcomes from their spending on these treatments.”